Citation

Ohtake Y, Sato T, Matsuoka H, Kobayashi T, Nishimoto M, Taka N, Takano K, Yamamoto K, Ohmori M, Higuchi T, Murakata M, Morikawa K, Shimma N, Suzuki M, Hagita H, Ozawa K, Yamaguchi K, Kato M, Ikeda S.: C-Aryl 5a-carba-β-d-glucopyranosides as novel sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes. Bioorg Med Chem, Volume 20 (13), 2012

Authors

Hagita H, Higuchi T, Ikeda S., Kato M, Kobayashi T, Matsuoka H, Morikawa K, Murakata M, Nishimoto M, Ohmori M, Ohtake Y, Ozawa K, Sato T, Shimma N, Suzuki M, Taka N, Takano K, Yamaguchi K, Yamamoto K

Journal

Bioorg Med Chem

Year

2012

DOI

10.1016/j.bmc.2012.04.053

PubMed

22652255

Machine-readable

REST APIRDF